Quantum BioPharma 加入這一趨勢，將 100 萬美元的資金投入比特幣

埃里溫 (CoinChapter.com)——Quantum BioPharma 透露其於 12 月 20 日購買了 100 萬美元的比特幣和其他加密貨幣。

Quantum BioPharma (NASDAQ: QBIO) announced on Tuesday that it purchased $1 million worth of Bitcoin and other cryptocurrencies. This decision is part of the company’s strategy to diversify its treasury and engage in cryptocurrency transactions. However, the announcement led to a 10% drop in its Nasdaq shares.

Quantum BioPharma（納斯達克股票代碼：QBIO）週二宣布購買了價值 100 萬美元的比特幣和其他加密貨幣。這項決定是該公司財務多元化和從事加密貨幣交易策略的一部分。然而，這項消息導致其納斯達克股價下跌10%。

The company did not disclose which specific tokens were included in its cryptocurrency portfolio. In a statement, Quantum BioPharma said it is now equipped to receive financing and conduct transactions using cryptocurrency.

該公司並未透露其加密貨幣投資組合中包含哪些具體代幣。 Quantum BioPharma 在一份聲明中表示，它現在有能力接受融資並使用加密貨幣進行交易。

Increasing Corporate Adoption of Bitcoin

越來越多的企業採用比特幣

Quantum BioPharma’s move reflects a growing trend of companies adopting Bitcoin and other cryptocurrencies as part of their treasury management strategies. In November, Jiva Technologies, a wellness-focused e-commerce company, invested $1 million in Bitcoin, citing its potential as an inflation hedge. Similarly, video-sharing platform Rumble allocated $20 million from its cash reserves to Bitcoin last month.

Quantum BioPharma 的舉動反映了越來越多的公司採用比特幣和其他加密貨幣作為其財務管理策略的一部分。去年 11 月，專注於健康的電子商務公司 Jiva Technologies 投資了 100 萬美元比特幣，理由是比特幣具有對沖通貨膨脹的潛力。同樣，視頻共享平台 Rumble 上個月從其現金儲備中撥出 2000 萬美元購買比特幣。

Another biopharmaceutical company, Hoth Therapeutics, also joined the trend by investing $1 million in Bitcoin in November. These investments highlight the increasing interest of non-crypto businesses in digital assets.

另一家生物製藥公司 Hoth Therapeutics 也加入了這一趨勢，於 11 月投資了 100 萬美元的比特幣。這些投資凸顯了非加密企業對數位資產日益增長的興趣。

Cryptocurrency as a Hedge Against Inflation

加密貨幣作為通膨對沖工具

The latest US Consumer Price Index (CPI) data indicates that inflation rose by 2.7% year-over-year in November 2024, compared to 2.6% in October. This marks the sharpest monthly increase in seven months.

最新的美國消費者物價指數（CPI）數據顯示，2024 年 11 月通膨年增 2.7%，而 10 月為 2.6%。這標誌著七個月來的最大月度增幅。

Companies are looking to Bitcoin as a potential hedge against such inflationary pressures, driving further interest in cryptocurrency treasury strategies.

該公司正在將比特幣視為對抗此類通膨壓力的潛在對沖工具，這進一步推動了人們對加密貨幣財務策略的興趣。

Quantum BioPharma’s Role in Biotech and Crypto Adoption

量子生物製藥在生物技術和加密貨幣採用中的作用

Quantum BioPharma operates in the biopharmaceutical sector, offering biotech solutions for treating neurodegenerative diseases, metabolic syndromes, and alcohol misuse disorders. Listed on the Nasdaq, Canadian Securities Exchange, and Frankfurt Stock Exchange, the company is part of a broader movement integrating cryptocurrencies into traditional industries.

Quantum BioPharma 從事生物製藥領域的業務，提供治療神經退化性疾病、代謝症候群和酒精濫用障礙的生物技術解決方案。該公司在納斯達克、加拿大證券交易所和法蘭克福證券交易所上市，是加密貨幣融入傳統產業的更廣泛運動的一部分。

By adopting cryptocurrency for treasury management and transactions, Quantum BioPharma reflects the increasing synergy between traditional industries and digital assets.

透過採用加密貨幣進行資金管理和交易，量子生物製藥體現了傳統產業與數位資產之間日益增強的協同作用。

Push for Bitcoin in Corporate Treasuries

推動比特幣進入企業金庫

Organizations are also encouraging major corporations to explore Bitcoin. The National Center for Public Policy Research, a think tank based in Washington, recently proposed that Microsoft and Amazon consider Bitcoin treasury strategies.

各組織也鼓勵大公司探索比特幣。總部位於華盛頓的智庫國家公共政策研究中心最近提議微軟和亞馬遜考慮比特幣金庫策略。

At Microsoft’s annual meeting on Dec. 10, shareholders voted against this proposal, with the company labeling it “unnecessary.” Amazon shareholders are set to discuss a similar resolution in April 2025. The think tank plans to continue advocating for Bitcoin adoption in corporate treasuries in 2025.

在 12 月 10 日的微軟年會上，股東們投票反對了這項提議，公司稱其「沒有必要」。亞馬遜股東將於 2025 年 4 月討論類似的決議。

MicroStrategy Leads Bitcoin Holdings

MicroStrategy 引領比特幣持有量

Among corporations, MicroStrategy remains the largest Bitcoin holder, with 439,000 BTC as of December 2024. The company’s long-standing strategy of acquiring Bitcoin has influenced other firms, including Quantum BioPharma, to explore cryptocurrency as part of their treasury assets.

在企業中，MicroStrategy 仍然是最大的比特幣持有者，截至2024 年12 月，擁有439,000 比特幣。其庫存資產的一部分。

Quantum BioPharma’s $1 million investment in Bitcoin places it among a growing list of companies integrating digital assets into their financial strategies.

Quantum BioPharma 對比特幣的 100 萬美元投資使其成為越來越多將數位資產納入其財務策略的公司之一。